头颈癌放疗综合毒性风险分析:个体化优化治疗新概念
模型涉及14个器官,口腔与12种毒性相关,内部验证中位AUC为0.71,外部验证为0.67。该综合毒性风险谱支持同时平衡多种毒性风险以优化放疗。
要点
- 口腔是与12种毒性相关的主要器官,腮腺、颌下腺、颊黏膜和吞咽肌也重要。
- 模型中位AUC内部验证0.71、外部验证0.67,支持个体化多毒性风险优化。
核心结论
- 建立涵盖多种急性和晚期毒性的综合个体毒性风险谱,支持同时平衡多种毒性风险以优化头颈癌放疗。
主要发现
- NTCP模型涉及14个器官,口腔与12种毒性相关,为最主要器官。
- 腮腺、颌下腺、颊黏膜和吞咽肌也是重要器官。
- 基线毒性、治疗方式和肿瘤部位是毒性的常见预测因素。
- 模型中位区分度AUC内部验证为0.71(四分位距0.68-0.75),外部验证为0.67(四分位距0.62-0.71)。
关键数值与推荐
- 毒性涵盖吞咽、唾液、黏膜、言语、疼痛和一般不适。
- 预测因素包括患者、肿瘤和治疗特征及28个器官的剂量参数。
临床怎么用
- 可利用综合NTCP风险谱同时评估多种毒性风险,支持头颈癌个体化放疗优化以降低总体毒性负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: A comprehensive individual toxicity risk profile is needed to improve radiation treatment optimisation, minimising toxicity burden, in head and neck cancer (HNC) patients. We aimed to develop and externally validate NTCP models for various toxicities at multiple time points. MATERIALS AND METHODS: Using logistic regression, we determined the relationship between normal tissue irradiation and the risk of 22 toxicities at ten time points during and after treatment in 750 HNC patients. The toxicities involved swallowing, salivary, mucosal, speech, pain and general complaints. Studied predictors included patient, tumour and treatment characteristics and dose parameters of 28 organs. The resulting NTCP models were externally validated in 395 HNC patients. RESULTS: The NTCP models involved 14 organs that were associated with at least one toxicity. The oral cavity was the predominant organ, associated with 12 toxicities. Other important organs included the parotid and submandibular glands, buccal mucosa and swallowing muscles. In addition, baseline toxicity, treatment modality, and tumour site were common predictors of toxicity. The median discrimination performance (AUC) of the models was 0.71 (interquartile range: 0.68-0.75) at internal validation and 0.67 (interquartile range: 0.62-0.71) at external validation. CONCLUSION: We established a comprehensive individual toxicity risk profile that provides essential insight into how radiation exposure of various organs translates into multiple acute and late toxicities. This comprehensive understanding of radiation-induced toxicities enables a new radiation treatment optimisation concept that balances multiple toxicity risks simultaneously and minimises the overall toxicity burden for an individual HNC patient who needs to undergo radiation treatment.
引用
- Van den Bosch L, van der Schaaf A, van der Laan HP, et al. Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment. Radiother Oncol. 2021. PMID: 33545258. doi:10.1016/j.radonc.2021.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。